Maintenance Notice (3:30 - 10:00 AM December 21, 2024 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | Notice of Discontinuing the Use of Password-Protected Compressed Files | Product Document Searching Made Easy by 2D Code! | TCI Life Science News December 2024 | [TCIPracticalExample] Reduction of Amide Group Using... | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 24729-96-2 | Product Number: C2257
Clindamycin Phosphate
×
![]()
×
Purity: >97.0%(T)
Synonyms:
- Clindamycin 2-Dihydrogen Phosphate
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days |
|---|---|---|---|
| 5G |
$90.00
|
16 | ≥80 |
| 25G |
$246.00
|
25 | Contact Us |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | C2257 |
| Purity / Analysis Method | >97.0%(T) |
| Molecular Formula / Molecular Weight | C__1__8H__3__4ClN__2O__8PS = 504.96 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 24729-96-2 |
| Reaxys Registry Number | 463386 |
| PubChem Substance ID | 87560447 |
| Merck Index (14) | 2356 |
| MDL Number | MFCD07793328 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(Nonaqueous Titration) | min. 97.0 %(calcd.on anh.substance) |
| Specific rotation [a]20/D | +115.0 to +130.0 deg(C=1, H2O)(calcd.on anh.substance) |
| Water | max. 6.0 % |
Properties (reference)
| Melting Point | 114 °C |
| Specific Rotation | 122° (C=1,H2O) |
| Solubility in water | Soluble |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
| RTECS# | GF2625000 |
Transport Information:
| H.S.code* | 2941.90-000 |
Application
Clindamycin Phosphate: A Water Soluble Clindamycin
Clindamycin phosphate is a prodrug of lincosamide antibiotic clindamycin hydrochloride [C2256], and is designed as a highly water soluble form of the poorly water soluble parent compound clindamycin. Meanwhile, clindamycin phosphate has been used as a chiral selector.
References
- Parenteral development of clindamycin-2-phosphate (a review)
- K. W. Riebe, T. O. Oesterling, Bull. Parenteral Drug Assoc. 1972, 26, 139.
- Case Study: Clindamycin 2-Phosphate, A Prodrug of Clindamycin (a review)
- Investigation of enantiomeric separation of basic drugs by capillary electrophoresis using clindamycin phosphate as a novel chiral selector
- Evaluation of the enantioseparation capability of the novel chiral selector clindamycin phosphate towards basic drugs by micellar electrokinetic chromatography
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.